RA Capital Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-585,890
| Closed | -$1.69M | – | 35 |
|
|
2017
Q4 | $1.69M | Sell |
585,890
-13,047,330
| -96% | -$37.6M | 0.14% | 27 |
|
|
2017
Q3 | $61.2M | Hold |
13,633,220
| – | – | 5.53% | 5 |
|
|
2017
Q2 | $62.6M | Hold |
13,633,220
| – | – | 7.18% | 4 |
|
|
2017
Q1 | $57.4M | Hold |
13,633,220
| – | – | 7.04% | 4 |
|
|
2016
Q4 | $56.3M | Buy |
13,633,220
+1,600,000
| +13% | +$6.61M | 7.98% | 4 |
|
|
2016
Q3 | $97.5M | Hold |
12,033,220
| – | – | 10.05% | 2 |
|
|
2016
Q2 | $93.9M | Hold |
12,033,220
| – | – | 13% | 2 |
|
|
2016
Q1 | $92.9M | Buy |
12,033,220
+810,327
| +7% | +$6.26M | 11.87% | 2 |
|
|
2015
Q4 | $121M | Sell |
11,222,893
-510,922
| -4% | -$5.51M | 11.98% | 1 |
|
|
2015
Q3 | $81.1M | Buy |
11,733,815
+1,787,818
| +18% | +$12.4M | 11.64% | 1 |
|
|
2015
Q2 | $88.1M | Buy |
9,945,997
+1,738,467
| +21% | +$15.4M | 8.86% | 2 |
|
|
2015
Q1 | $80.9M | Buy |
8,207,530
+1,507,530
| +23% | +$14.9M | 8.04% | 1 |
|
|
2014
Q4 | $82.1M | Hold |
6,700,000
| – | – | 8.82% | 2 |
|
|
2014
Q3 | $66.9M | Sell |
6,700,000
-15,786,007
| -70% | -$158M | 7.9% | 3 |
|
|
2014
Q2 | $170M | Sell |
22,486,007
-880,000
| -4% | -$6.66M | 17.21% | 1 |
|
|
2014
Q1 | $76.9M | Hold |
23,366,007
| – | – | 5.51% | 2 |
|
|
2013
Q4 | $77.6M | Buy |
23,366,007
+8,908,946
| +62% | +$29.6M | 9.03% | 1 |
|
|
2013
Q3 | $43.7M | Buy |
14,457,061
+7,001,859
| +94% | +$21.1M | 4.56% | 7 |
|
|
2013
Q2 | $61M | Buy |
+7,455,202
| New | +$61M | 8.09% | 2 |
|